Hyunsik Choi , Bolam Kim , Yewon Seo , Tae Yeon Kim , Ki Wan Bong , Sei Kwang Hahn
{"title":"磁控干细胞微凝胶机器人治疗间质性膀胱炎","authors":"Hyunsik Choi , Bolam Kim , Yewon Seo , Tae Yeon Kim , Ki Wan Bong , Sei Kwang Hahn","doi":"10.1016/j.biomaterials.2025.123551","DOIUrl":null,"url":null,"abstract":"<div><div>Stem cell therapy has been widely investigated for the treatment of chronic bladder diseases such as interstitial cystitis/bladder pain syndrome (IC/BPS). However, the delivery of stem cells into the bladder wall is limited due to the mucus layer lining the bladder wall and the frequent urination, leading to the fast clearance of stem cells from the bladder. Here, we report a soft microgelbot (μgelbot) composed of a magnetic nanochain embedded microgel in a tunable size and shape for the enhanced delivery of mesenchymal stem cells (MSCs) into the bladder wall through the mucus layer. <em>In vitro</em> penetration tests to optimize the shape of μgelbots show that the quadrangle shaped μgelbots effectively apply a shear force to the surrounding shear-thinning mucus layer for the enhanced penetration under a rotating magnetic field. After loading MSCs onto the μgelbot, we confirm the enhanced penetration and retention in the reconstructed mucus layer. Finally, we successfully demonstrate the paracrine effects of MSCs loaded μgelbots on chronic IC murine models, inhibiting the mast cell infiltration, collagen deposition, and bladder cell apoptosis. Taken together, we could confirm the feasibility of magnetically controlled μgelbots as a promising platform for the stem cell therapy of IC/BPS.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"325 ","pages":"Article 123551"},"PeriodicalIF":12.8000,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Magnetically controlled microgelbots with stem cells for the treatment of interstitial cystitis\",\"authors\":\"Hyunsik Choi , Bolam Kim , Yewon Seo , Tae Yeon Kim , Ki Wan Bong , Sei Kwang Hahn\",\"doi\":\"10.1016/j.biomaterials.2025.123551\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Stem cell therapy has been widely investigated for the treatment of chronic bladder diseases such as interstitial cystitis/bladder pain syndrome (IC/BPS). However, the delivery of stem cells into the bladder wall is limited due to the mucus layer lining the bladder wall and the frequent urination, leading to the fast clearance of stem cells from the bladder. Here, we report a soft microgelbot (μgelbot) composed of a magnetic nanochain embedded microgel in a tunable size and shape for the enhanced delivery of mesenchymal stem cells (MSCs) into the bladder wall through the mucus layer. <em>In vitro</em> penetration tests to optimize the shape of μgelbots show that the quadrangle shaped μgelbots effectively apply a shear force to the surrounding shear-thinning mucus layer for the enhanced penetration under a rotating magnetic field. After loading MSCs onto the μgelbot, we confirm the enhanced penetration and retention in the reconstructed mucus layer. Finally, we successfully demonstrate the paracrine effects of MSCs loaded μgelbots on chronic IC murine models, inhibiting the mast cell infiltration, collagen deposition, and bladder cell apoptosis. Taken together, we could confirm the feasibility of magnetically controlled μgelbots as a promising platform for the stem cell therapy of IC/BPS.</div></div>\",\"PeriodicalId\":254,\"journal\":{\"name\":\"Biomaterials\",\"volume\":\"325 \",\"pages\":\"Article 123551\"},\"PeriodicalIF\":12.8000,\"publicationDate\":\"2025-07-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomaterials\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0142961225004703\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomaterials","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0142961225004703","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Magnetically controlled microgelbots with stem cells for the treatment of interstitial cystitis
Stem cell therapy has been widely investigated for the treatment of chronic bladder diseases such as interstitial cystitis/bladder pain syndrome (IC/BPS). However, the delivery of stem cells into the bladder wall is limited due to the mucus layer lining the bladder wall and the frequent urination, leading to the fast clearance of stem cells from the bladder. Here, we report a soft microgelbot (μgelbot) composed of a magnetic nanochain embedded microgel in a tunable size and shape for the enhanced delivery of mesenchymal stem cells (MSCs) into the bladder wall through the mucus layer. In vitro penetration tests to optimize the shape of μgelbots show that the quadrangle shaped μgelbots effectively apply a shear force to the surrounding shear-thinning mucus layer for the enhanced penetration under a rotating magnetic field. After loading MSCs onto the μgelbot, we confirm the enhanced penetration and retention in the reconstructed mucus layer. Finally, we successfully demonstrate the paracrine effects of MSCs loaded μgelbots on chronic IC murine models, inhibiting the mast cell infiltration, collagen deposition, and bladder cell apoptosis. Taken together, we could confirm the feasibility of magnetically controlled μgelbots as a promising platform for the stem cell therapy of IC/BPS.
期刊介绍:
Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.